| Marian Eldridge Morris, MD | |
|
411 E Chestnut St # 1, Louisville, KY 40202-1713 | |
| (502) 588-3440 | |
| (502) 588-3441 |
| Full Name | Marian Eldridge Morris |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 411 E Chestnut St # 1, Louisville, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023383395 | NPI | - | NPPES |
| 7100256830 | Medicaid | KY | |
| 201289520 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 47954 (Kentucky) | Primary |
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
Continual genomic surveillance of the SARS-CoV-2 strains in South Africa has revealed an increase in the number of sequences belonging to C.1 lineage during the third wave (May 2021) of SARS-CoV-2 infections. This observation was unexpected because C.1 was last reported in January 2021.
Researchers at the University of Michigan Health System have found a key linkage between pain and a specific brain molecule, a discovery that lends new insight into fibromyalgia, an often-baffling chronic pain condition.
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.
A Major League Baseball player's natural sleep preference might affect his batting average in day and night games, according to a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.
› Verified 1 days ago
| Entity Name | Norton Childrens Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326695255 PECOS PAC ID: 3779917596 Enrollment ID: O20200102000758 |
News Archive
Continual genomic surveillance of the SARS-CoV-2 strains in South Africa has revealed an increase in the number of sequences belonging to C.1 lineage during the third wave (May 2021) of SARS-CoV-2 infections. This observation was unexpected because C.1 was last reported in January 2021.
Researchers at the University of Michigan Health System have found a key linkage between pain and a specific brain molecule, a discovery that lends new insight into fibromyalgia, an often-baffling chronic pain condition.
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.
A Major League Baseball player's natural sleep preference might affect his batting average in day and night games, according to a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marian Eldridge Morris, MD Po Box 776879, Chicago, IL 60677-6879 Ph: (502) 588-9490 | Marian Eldridge Morris, MD 411 E Chestnut St # 1, Louisville, KY 40202-1713 Ph: (502) 588-3440 |
News Archive
Continual genomic surveillance of the SARS-CoV-2 strains in South Africa has revealed an increase in the number of sequences belonging to C.1 lineage during the third wave (May 2021) of SARS-CoV-2 infections. This observation was unexpected because C.1 was last reported in January 2021.
Researchers at the University of Michigan Health System have found a key linkage between pain and a specific brain molecule, a discovery that lends new insight into fibromyalgia, an often-baffling chronic pain condition.
BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.
A Major League Baseball player's natural sleep preference might affect his batting average in day and night games, according to a research abstract that will be presented Monday, June 13, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.
› Verified 1 days ago
Dr. Kendra Stratton Cloyd, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3026 Poplar Level Rd, Louisville, KY 40217 Phone: 502-636-4929 | |
Meredith Kay Irwin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 100 Mallard Creek Rd Ste 395, Louisville, KY 40207 Phone: 502-895-9421 Fax: 502-899-5762 | |
Julia E Richerson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2215 Portland Ave, Louisville, KY 40212 Phone: 502-774-8631 Fax: 502-776-8912 | |
Pradip D Patel, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9702 Stonestreet Rd, Ste 100, Louisville, KY 40272 Phone: 502-588-0610 Fax: 502-588-0611 | |
Patricia Gail Williams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 411 E Chestnut St, Louisville, KY 40202 Phone: 502-588-0850 Fax: 502-588-0861 | |
Teresa Crase, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9880 Angies Way, Ste. 400, Louisville, KY 40241 Phone: 502-394-6500 | |
Dr. Kenneth N Schikler, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 210 E Gray St, Ste 1000, Louisville, KY 40202 Phone: 502-629-7702 Fax: 502-629-3975 |